top of page


More accurate and cost-effective health management for the Greek citizen

Recent technological breakthroughs, such as rapid sequencing of the human genome and high-throughput profiling of epigenetic, metabolic and environmental influences in physiology and disease, have led to deeper understanding of the molecular basis of human pathologies, offering a unique potential to radically transform disease management in the coming decades. Personalised medicine/ healthcare (also known as stratified, precise or P4 medicine) has emerged as the next step in prevention and treatment of disease and refers to tailored medical treatments based on the individual characteristics of patients.


pMedGR aims to become a regional hub for the implementation, coordination and integration of personalized medicine approaches in South-East Europe, as part of a global network, offering centralized information on patient stratification, susceptibility factors and response to treatments for relevant regional populations. This hub will serve as a single entry point for researchers and industry with an interest in targeting this area. Greece’s strategic geopolitical position, which correlates with genetic characteristics that may be important to health and disease, render it ideal to serve as a paradigm for personalized approaches targeting an extended regional area, including south Italy, the Balkans, Turkey etc. Through pMedGR, Greece has the potential to become a South-East European Node for Personalized Medicine, linking Europe to emerging markets such as Asia, Africa and the Middle East.

Strategic development pipeline

Phase I:

(Year 1)

Preparatory phase



Feasibility study and Business plan, including funding sources, governance plan, sustainability, legal form, operational capacity, access policy, management structure etc.

(Month 6)


Mapping capacities and needs for the development of drug discovery pipelines by the academic, clinical and industrial community

(Month 12)


Stakeholder and user network building (including initial MoU, public and private investor networks, fund mobilization

(Month 12)


Phase II:

(Year 2-3)

Construction phase



Building and laboratory space preparations

(Month 18)


Procurement of high-end equipment and infrastructure development

(Month 18)


Recruitment and training of research and technology personnel

(Month 24)


Set up of new equipment and optimization of usage

(Month 30)


Demonstration projects and pilot studies 

(Month 36)


Standard operating procedures and protocol development

(Month 36)


Phase III:

(Year 4-5)

Full implementation and operational capacity


Build-up of operational capacity

(Month 48)


Optimisation of services and access policies 

(Month 48)


Transnational access services

(Month 54)


Technology transfer protocols and IP exploitation

(Month 54)


Public-private partnership building and investment recruitment

(Month 60)


bottom of page